NP42824 Unlicensed Imported Medicines
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £8,692,952 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | Scotland |
| Deadline | 19 Jan 2024 |
| Procedure | open |
| OCID | ocds-h6vhtk-042204 |
Awards (10)
This procurement was awarded to 10 suppliers. Values shown are per-award; the notice total is £8,692,952.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Alium Medical Ltd shared | · | · | active |
| Clinigen Healthcare Ltd shared | · | · | · |
| Durbin PLC shared | · | · | active |
| Inceptua Limited shared | · | · | · |
| IPS Pharma shared | · | · | active |
| Mawdsley Brooks & Co Ltd shared | · | · | active |
| Orifarm Supply A/S shared | · | · | active |
| Qmed Pharmaceuticals Ltd shared | · | · | active |
| Smartway Pharmaceuticals Ltd shared | · | · | active |
| Target Healthcare Limited shared | · | · | · |
description
The supply of unlicensed imported medicines to NHS Scotland.
documents
- NP42824 Unlicensed Imported Medicines , awardNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 6 Dec 2023 | Contract notice (F02) | Earlier regulations | 035894-2023 |
| 1 May 2024 | Contract award notice (F03) | Earlier regulations | 014049-2024 |
more from NHS Scotland
- NP49124 Hepatitis C Medicines · £36,556,082 · 21 Mar 2024
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Public Contracts Scotland. Contact details for named individuals are not reproduced on this site.